Smiths Group plc

Public consensus   -   Last updated 29/04/19

Reporting currency: GBP
Reporting unit: Absolute
 
NO. OF
FORECASTS
FY19
CONSENSUS
29/04/19
FY19
MIN
FY19
MAX
Smiths Group plc
Revenue (£ Millions)
John Crane
11
928
909
947
Medical
11
886
872
905
Detection
11
821
809
832
Interconnect
11
318
303
324
Flex-Tek
11
425
403
460
Total Revenue
11
3,379
3,342
3,426
Operating Profit (£ Millions)
John Crane
11
214
209
218
Medical
11
152
147
162
Detection
11
138
132
144
Interconnect
11
46
43
48
Flex-Tek
11
79
75
85
Corporate
11
(58)
(60)
(55)
Total Operating Profit
11
573
562
588
Operating Margin %
John Crane
11
23.1
22.6
23.5
Medical
11
17.2
16.7
18.2
Detection
11
16.8
16.1
17.5
Interconnect
11
14.6
13.6
15.0
Flex-Tek
11
18.7
18.1
19.0
Total - Operating Margin
11
16.9
16.7
17.3
Net financing
11
(59)
(65)
(52)
PBT
11
510
455
536
Tax rate
10
23.1
-
26.0
Tax
9
(133)
(139)
(129)
Net Income
11
376
314
395
Number of shares
11
397.12
395.12
402.00
EPS (p)
11
94.76
79.35
99.71
DPS (p)
11
46.07
45.47
46.90
Change in WC
6
(19)
(60)
10
D&A
6
102
-
132
Operating CF
7
440
-
601
FCF
6
246
-
421
Net debt
9
955
739
1,087
GBP/EUR
6
0.95
-
1.16
GBP/USD
6
1.08
-
1.31

Disclaimer

* Headline profit is before exceptional items, amortisation and impairment of acquired intangible assets and financing gains/losses from currency hedging.
* The United Flexible acquisition which has now completed is included in the numbers.

Each line is the average for the analysts' forecasts for that item and as such the numbers do not always total correctly because of rounding differences.

The forecasts in this analysis have been gathered from a number of registered investment analysts and are, as such, publicly available information. These estimates are forward looking and are therefore subject to risks and uncertainties that may materially affect eventual results. In distributing this analysis, Smiths Group does not imply its endorsement of, or concurrence with, such information, conclusions or recommendations. Nothing in this analysis should be taken as a recommendation to buy or sell shares in Smiths Group or to take any other action or place any reliance on the analysis. Smiths Group is not regulated by the Financial Conduct Authority and cannot offer investment advice.

Although Smiths Group will endeavour to procure that the information is kept updated, Smiths Group assumes no obligation to update or revise such information to reflect circumstances existing after the date hereof. Neither Smiths Group nor any subsidiary undertaking or any director, officer or employee of Smiths Group accepts any responsibility for the accuracy of the forecasts used in this analysis and therefore shall have no liability whatsoever for the consequences of any reliance or actions taken or not taken based on any of the information in this analysis.